Fatigue predicts quality of life after leucine‐rich glioma‐inactivated 1‐antibody encephalitis

Fatigue predicts quality of life after leucine‐rich glioma‐inactivated 1‐antibody encephalitis

Abstract Patient‐reported quality‐of‐life (QoL) and carer impacts are not reported after leucine‐rich glioma‐inactivated 1‐antibody encephalitis (LGI1‐Ab‐E). From 60 patients, 85% (51 out of 60) showed one abnormal score across QoL assessments and 11 multimodal validated questionnaires. Compared to...

Full description

Bibliographic Details
Main Authors:	Sophie N. M. Binks, Michele Veldsman, Adam E. Handel, Saiju Jacob, Paul Maddison, Jan Coebergh, Sophia Michael, Sudarshini Ramanathan, Ava Easton, Mette Scheller Nissen, Maria Isabel Leite, David Okai, Morten Blaabjerg, Masud Husain, Sarosh R. Irani
Format:	Article
Language:	English
Published:	Wiley 2024-04-01
Series:	Annals of Clinical and Translational Neurology
Online Access:	https://doi.org/10.1002/acn3.52006

Similar Items

Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis
by: Binks, SNM, et al.
Published: (2024)

Cognitive, neuropsychiatric and quality-of-life sequelae in LGI1-antibody disease demonstrates fatigue as the key determinant of wellbeing
by: Binks, S, et al.
Published: (2020)

Anti-IgLON5 Disease: A Case With 11-Year Clinical Course and Review of the Literature
by: Mette Scheller Nissen, et al.
Published: (2019-10-01)

‘Less contented as a person’: an update from the LGI1-QoL study
by: Binks, S, et al.
Published: (2019)

CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study
by: Mette Scheller Nissen, et al.
Published: (2021-12-01)

Tick-borne encephalitis as a trigger for anti-N-Methyl-d-aspartate receptor encephalitis
by: Thomas Agerbo Gaist, et al.
Published: (2024-03-01)

‘Less contented as a person’: preliminary data from the LGI1-QoL study
by: Binks, S, et al.
Published: (2017)

Antibody targets in autoimmune encephalitis
by: Irani, S, et al.
Published: (2010)

Leucine-Rich Glioma-Inactivated 1 Encephalitis: Broadening the Sphere
by: Amine Rachdi, et al.
Published: (2019-10-01)

Limbic encephalitis associated with leucine-rich glioma-inactivated 1 antibodies
by: Mariem Messelmani, et al.
Published: (2015-01-01)

Changes in the rate of leucine-rich glioma-inactivated 1 seropositivity during the COVID-19 lockdown
by: Handel, AE, et al.
Published: (2023)

Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis.
by: Naasan, G, et al.
Published: (2014)

Pathophysiological Effects of Autoantibodies in Autoimmune Encephalitides
by: Matias Ryding, et al.
Published: (2023-12-01)

EEG characteristics of anti ⁃ leucine ⁃ rich glioma ⁃ inactivated 1 antibody ⁃ associated encephalitis
by: ZHANG Yi⁃fan, et al.
Published: (2023-12-01)

Clinical characteristics of anti ⁃ leucine ⁃ rich glioma ⁃ inactivated 1 antibody associated encephalitis
by: PAN He⁃yue, et al.
Published: (2023-10-01)

Clinical analysis of anti⁃leucine⁃rich glioma⁃inactivated 1 antibody⁃related encephalitis
by: Qing⁃qing ZHAO, et al.
Published: (2020-09-01)

Magnetic resonance imaging characteristics of LGI1-antibody and CASPR2-antibody encephalitis
by: Kelly, MJ, et al.
Published: (2024)

Editorial: Emerging Challenges in the Diagnosis and Treatment of Autoimmune Encephalitis
by: Morten Blaabjerg, et al.
Published: (2019-02-01)

Use of Cerebrospinal Fluid Biomarkers in Diagnosis and Monitoring of Rheumatoid Meningitis
by: Mette Scheller Nissen, et al.
Published: (2019-06-01)

Long-term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis.
by: Brown, J, et al.
Published: (2014)

What should you know about limbic encephalitis?
by: Sara Machado, et al.
Published: (2012-10-01)

The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data
by: Al-Diwani, A, et al.
Published: (2019)

Anti-Leucine-Rich Glioma-Inactivated 1 Encephalitis: A Single-Center Cohort Study in China
by: FAN Siyuan, et al.
Published: (2022-04-01)

Anti-leucine-rich glioma-inactivated 1 encephalitis: two case reports and a review of the literature
by: Sanaz Ahmadi Karvigh, et al.
Published: (2022-11-01)

Clinical analysis of patients with anti-leucine-rich glioma-inactivated 1 antibody-associated limbic encephalitis
by: Jia-qian TANG, et al.
Published: (2019-04-01)

CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients
by: Lin Y, et al.
Published: (2019-10-01)

The initial MRI was negative in leucine⁃rich glioma⁃inactivated 1 antibody encephalitis: one case report
by: CAI Tong⁃tong, et al.
Published: (2021-07-01)

Persistent hiccup as one of the initial symptoms of leucine-rich glioma-inactivated-1 encephalitis: a case report
by: Lan Hou, et al.
Published: (2022-07-01)

CXCL13 Is a Biomarker of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients [Letter]
by: Wei M, et al.
Published: (2020-01-01)

Clinical Features and Therapeutic Effects of Anti-leucine-rich Glioma Inactivated 1 Encephalitis: A Systematic Review
by: Yuou Teng, et al.
Published: (2022-01-01)

Discrimination between leucine-rich glioma-inactivated 1 antibody encephalitis and gamma-aminobutyric acid B receptor antibody encephalitis based on ResNet18
by: Jian Pan, et al.
Published: (2023-08-01)

The immunogenetics of LGI1- and CASPR2-antibody encephalitis: towards aetiology
by: Binks, S
Published: (2022)

Leucine-rich glioma-inactivated 1 versus contactin-associated protein-like 2 antibody neuropathic pain: clinical and biological comparisons
by: Ramanathan, S, et al.
Published: (2021)

RETROGRADE AMNESIA FOLLOWING AUTOIMMUNE LIMBIC ENCEPHALITIS
by: Miller, T, et al.
Published: (2014)

Novel Surrogate Markers of CNS Inflammation in CSF in the Diagnosis of Autoimmune Encephalitis
by: Jocelyn X. Jiang, et al.
Published: (2020-02-01)

Clinical and electroencephalographic characteristics of symptomatic episodes in anti⁃leucine rich glioma inactivated 1 antibody⁃associated autoimmune encephalitis
by: LI Cheng⁃yu, et al.
Published: (2023-03-01)

CHI3L1 in the CSF is a potential biomarker for anti-leucine-rich glioma inactivated 1 encephalitis
by: Jinyi Li, et al.
Published: (2023-01-01)

A case of leucine-rich glioma-inactivated 1 antibody encephalitis with schizophrenia-like symptoms as an initial clinical manifestation
by: Jiyeon Moon, et al.
Published: (2022-10-01)

Serial assessment of multimodality imaging in anti-leucine-rich glioma-inactivated 1 antibody encephalitis: A case report
by: Takafumi Wada, et al.
Published: (2022-12-01)

Clinical Features and Gut Microbial Alterations in Anti-leucine-rich Glioma-Inactivated 1 Encephalitis—A Pilot Study
by: Xueying Ma, et al.
Published: (2020-10-01)